Corticosteroids for pneumonia: are we there yet?
- PMID: 23134329
- PMCID: PMC3556208
- DOI: 10.1111/resp.12012
Corticosteroids for pneumonia: are we there yet?
Conflict of interest statement
The time to write this Editorial for MIR is partially protected by Award Number K23HL096054 from the National Heart, Lung, And Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, And Blood Institute or the National Institutes of Health. MIR participated as a consultant in data safety monitoring boards for clinical trials performed by Theravance and Trius. The time of OS is supported by the Instituto de Salud Carlos III (BAE11/00102) and Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR).
Comment on
-
Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome.Respirology. 2013 Feb;18(2):263-71. doi: 10.1111/resp.12013. Respirology. 2013. PMID: 23134361
References
-
- Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281:61–66. - PubMed
-
- Wunderink RG, Mandell L. Adjunctive therapy in community acquired pneumonia. Semin Respir Crit Care. 2012;33:311–318. - PubMed
-
- Rhen T, Cidlowsky JA. Antiinflammatory action of glucocorticoids – new mechanisms for old drugs. N Eng J Med. 2005;353:1711–23. - PubMed
-
- Sibila O, Luna CM, Agusti C, et al. Effects of glucocorticoids in ventilated piglets with severe pneumonia. Eur Respir J. 2008;32:1037–46. - PubMed
-
- Polverino E, Cilloniz C, Dambrava P, et al. Systemic corticosteroids for CAP: reasons for use and lack of benefit on outcome. Respirology. 2013;18(2) - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical